Clobetasol Propionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 9 EU WC, 18 KDMF, 15 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

FINISHED DOSAGE FORMULATIONS

212 FDF Dossiers, 98 FDA Orange Book, 45 Europe, 25 Canada, 1 Australia, 9 South Africa, 34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.025%, AEROSOL, FOAM;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, SHAMPOO;TOPICAL - 0.05%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 9 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 14 Corel Pharma Chem, 1 Finar, 9 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 39 Topical, 23 Solubilizers, 21 Controlled & Modified Release, 14 Emulsifying Agents, 13 Thickeners and Stabilizers, 12 Surfactant & Foaming Agents, 12 Parenteral, 12 Film Formers & Plasticizers, 7 Co-Processed Excipients, 6 Granulation, 6 Direct Compression, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Rheology Modifiers, 3 Fillers, Diluents & Binders, 3 Lubricants & Glidants, 2 Coloring Agents, 1 Disintegrants & Superdisintegrants, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 81 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 54 Finished Drug Prices

MARKET PLACE

20 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 1 JP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22013 / DOSAGE - AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CLOBETASOL PROPIONATE(UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H)	CLOBETASOL PROPIONATE	0.5mg in 1

Inactive Ingredients

Ingredient Name	Prestium Pharma, Inc.	Renaissance Pharma, Inc.
ANHYDROUS CITRIC ACID(XF417D3PSL)
CETYL ALCOHOL(936JST6JCN)
CYCLOMETHICONE(NMQ347994Z)
ISOPROPYL MYRISTATE(0RE8K4LNJS)
LIGHT MINERAL OIL(N6K5787QVP)
PETROLATUM(4T6H12BN9U)
PHENOXYETHANOL(HIE492ZZ3T)
POLYOXYL 20 CETOSTEARYL ETHER(YRC528SWUY)
POTASSIUM CITRATE(EE90ONI6FF)
PROPYLENE GLYCOL(6DC9Q167V3)
SORBITAN MONOLAURATE(6W9PS8B71J)
WATER(059QF0KO0R)

Drug Product Composition: Clobetasol Propionate